Birth weight and melanoma risk: a population-based case–control study by Franco-Lie, I et al.
Birth weight and melanoma risk: a population-based case–control
study
I Franco-Lie*,1, T Iversen
2, TE Robsahm
3 and M Abdelnoor
4
1Department for Research and Education, Center for Clinical Research, Ullevaal University Hospital, Oslo 0407, Norway;
2Department of Oncology, The
Norwegian Radium Hospital, Montebello, Oslo 0310, Norway;
3Cancer Registry of Norway, Montebello, Oslo 0310, Norway;
4Section for Epidemiology
and Biostatistics, Department for Research and Education, Center for Clinical Research, Ullevaal University Hospital, Oslo 0407, Norway
We investigated whether lower birth weight was associated with lower risk of melanoma later in life. This population-based case–
control study included all incident cases of histologically verified invasive melanoma diagnosed until 31 December 2003 in the
Norwegian population born between 1967 and 1986 (n¼709). The control group without malignant disease was established by
random sampling from the same source population as the cases (n¼108209). Data on birth weight, gender, mother’s residence and
parental age at the time of birth were collected from the Medical Birth Registry of Norway and data on cancer from the Cancer
Registry of Norway. The Mantel–Haenszel test of linear trend showed no trend in risk across the birth weight categories: individuals
in the highest quartile of birth weight (X3860g) had an odds ratio (OR) of 1.19 (95% confidence interval, CI: 0.77–1.84) compared
to individuals with birth weight o2500g. The adjusted OR was 0.81 (95% CI: 0.52–1.26) for birth weight below 2500g (exposed).
Though not statistically significant, the results suggest that low birth weight might influence the risk of melanoma later in life.
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Exposure to intermittent high-dose ultraviolet (UV) radiation is
widely recognised as the major cause of cutaneous malignant
melanoma (hence referred to as melanoma). In two previous
studies, we observed a lower incidence of melanoma in twins as
compared to singletons (Iversen et al, 2001; Franco-Lie et al, 2005)
as have others (Hemminki and Li, 2002; Hemminki and Chen,
2005; Neale et al, 2005), but for which no biological explanation is
evident.
Twins and singletons differ in mean birth weight, length at birth
and average duration of gestation. In the United States, mean
birth weight is 3351grams (g) for singletons and 2367g for twins
(Alexander et al, 1998), and Norwegian data are similar.
It has been hypothesised that birth weight can influence the
cancer risk later in life. This possible association has been studied
for melanoma (Andersson et al, 2001; McCormack et al, 2005;
Ahlgren et al, 2007) and other types of cancer (Le Marchand et al,
1988; Tibblin et al, 1995; Roman et al, 1997; Wandera ˚s et al, 1998;
Vatten et al, 2002; Hjalgrim et al, 2004; Nilsen et al, 2005; Michos
et al, 2007). The results are inconclusive; however, there seems to
be an association between birth weight and the risk for some
cancer forms.
We investigated whether lower birth weight is related to lower
risk of melanoma later in life by estimating the association
between birth weight and the incidence of melanoma in the
Norwegian population.
MATERIALS AND METHODS
This population-based study includes all live-born men and
women (n¼1142635) in Norway between 1 January 1967 and 31
December 1986. From this 20-year cohort, a case–control study
was carried out.
All incident cases of melanoma diagnosed in that population
before 31 December 2003 were identified (n¼859). Melanoma was
defined according to the international classification of diseases,
and only cases with histologically verified invasive melanoma of
primary tumour were included in the study (n¼711). The control
group is a random sample of the population, without a malignant
disease, born in the same period of time as the cases and in which
the individuals were all alive at the closing date 31 December 2003
(n¼109727).
For all the individuals, data on birth weight, gender, mother’s
residence and parental age at the time of birth, maternal pregnancy
factors and twin status were collected from the Medical Birth
Registry of Norway (MBRN). This is a population-based registry
based on compulsory notification of every birth or late abortion
with a gestational age of 16 weeks or more. Infants and parents can
be identified thorough the national 11-digit personal identification
number (Irgens, 2000).
Data on cancer were collected by linkage to the Cancer
Registry of Norway, using the unique 11-digit identification
number. The cancer registry is population-based (Cancer in
Norway, 2006).
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yCases without histological verification of the primary tumour
(n¼87) and cases of multiple cancers (n¼61) were excluded from
the analyses. Individuals lost to follow-up (controls, n¼3) and
individuals with follow-up shorter than 1 year (due to emigration
or death) were also excluded (case, n¼1; controls, n¼1324). This
1-year limit was based on the definition of infant mortality rate
(Gowen, 2006). Furthermore, individuals with missing data on
birth weight (case, n¼1; controls, n¼191) were also excluded.
The final study population includes 709 cases of melanoma and
108209 controls without a malignant disease.
The birth weight (g) was analysed both as a continuous variable
and as a categorical variable: o2500 and X2500g. The two
categories were defined by the low birth weight (LBW) limit of
2500g (Gowen, 2006). Birth weight was also analysed after
distribution into five categories. The lowest category is based on
the LBW limit and the others were based on quartile limits.
Norway is geographically spread from 58 to 721 latitude north
and the variation in UV radiation is large. The variable ‘place of
birth’, with the categories ‘North Norway’ and ‘South Norway’, was
created using the separation line located approximately at 621
latitude north.
The variables ‘mother’s age’ and ‘father’s age’ were polytomised
into quartiles, and the 75% quartile limits were used to create two
levels in each variable: younger and older parents. We have
missing data on father’s age (cases, n¼32 and controls, n¼8305).
Statistical analysis
We have used an explanatory aetiological strategy, where the
association of the exposition (birth weight) and the disease
(melanoma) was the major focus (Abdelnoor and Sandven, 2006).
The crude associations between the exposition birth weight and
the disease melanoma and between the covariates and the outcome
were estimated by the odds ratios (ORs) and the 95% confidence
interval limit (95% CI) (contingency tables). To calculate the effect
of the continuous variables, the Student’s t-test was used. The
gradient effect between different birth weight expositions and the
incidence of melanoma was done using the Mantel–Haenszel test
of linear trend. Stratified analysis (Mantel–Haenszel method) was
used to pinpoint effect modification via the Breslow–Day test of
heterogeneity. Quantification of confounding was done by
comparing the crude estimate of OR and the adjusted Mantel–
Haenszel OR. A logistic multivariable model was used to control
for multiconfounding (Kleinbaum et al, 1982). The statistical
analyses were performed using SPSS Version 14.0 for Windows
(SPSS Inc., Chicago, IL, USA). For the power calculation and for
the test of linear trend, Epi Info for Windows Version 3.3.2, 2005
(Centers for Disease Control and Prevention, Atlanta, GA, USA)
was used.
RESULTS
A total of 709 histologically verified incident cases of invasive
melanoma were diagnosed in the study population. The group of
cases had gender distribution of 68.0% women and 32.1% men.
The OR of melanoma for women was 2.35 (95% CI: 2.01–2.76) in
relation to men. The risk of melanoma was 30% higher (OR¼1.30,
95% CI: 1.09–1.55) for individuals born in the south, as compared
to individuals born in the north (Table 1). Evaluation of the
difference in maternal or paternal age at birth using t-test showed
no statistically significant difference between the case and the
control groups. Similarly, no difference was found when parental
age was assessed as a categorical variable (Table 1). Maternal
pregnancy factors such as preeclampsia/eclampsia, hypertension
during pregnancy and chronic kidney disease, occurred less
frequently among the cases; however, the difference was not
significant. Table 1 also shows that the risk of melanoma in twins
tends to be lower than in singletons (OR¼0.76, 95% CI: 0.40–
1.41) though not significantly, possibly due to lack of power.
Birth weight
The controls had a lower mean birth weight, regardless of whether
the genders were combined or separated for analysis (Table 1).
However, the difference was not statistically significant. Individuals
with a birth weight below 2500g tended to have a reduced risk
of melanoma (OR¼0.86, 95% CI: 0.57–1.31). In this study
population, the mean birth weights were 2640 and 3524g for
twins and singletons, respectively.
In the Mantel–Haenszel test of linear trend, the individuals in
the highest quartile of birth weight (X3860g) had an OR of 1.19
(95% CI: 0.77–1.84) compared to individuals in the lowest
category (o2500g) (Table 2). There was no trend in risk across
the distribution of birth weight.
Results from the stratified analysis, estimating the risk of
melanoma associated with birth weight, independent of gender,
showed the adjusted Mantel–Haenszel OR of 0.84 (95% CI: 0.55–
1.27), which corresponds to a confounding effect of –2.3%. The
confounding effect for each of the other variables in the analysis
(place of birth, mother’s and father’s ages at time of birth) was
below 5%. No effect modification was observed (data not shown).
Table 3 gives the results from the multiple logistic regression
analysis, estimating the effect of multiconfounders. Birth weight
below 2500g seems to reduce the risk of melanoma later in life,
also when possible confounding variables such as gender, place of
birth, maternal and paternal age were included in the analysis
(OR¼0.81, 95% CI: 0.52–1.26). The model confirmed the results
from the univariable analysis (Table 1).
A power calculation was performed for the effect of OR¼0.81,
considering the frequency of exposition to birth weight o2500g in
controls to be 3.7% (Table 1), with a type I error of 5% and with a
power of 80%. A sample size of 5864 cases of melanoma and
891328 controls would be needed to have a 80% chance to observe
a significant 19% reduction in melanoma risk in individuals with
birth weight below 2500g.
DISCUSSION
We questioned whether individuals with a LBW were less likely to
develop cutaneous malignant melanoma compared to individuals
with higher birth weight.
Results from the univariable and the multivariable analyses
indicate that birth weight might be associated with occurrence of
melanoma, also when other possible confounders, such as gender,
place of birth and parental age were included in the model.
In 2001, Andersson et al (2001) observed a 2-fold increase in
cancer risk in the highest quintile of birth weight compared to the
lowest quintile (relative risk (RR)¼2.07, 95% CI: 1.22–3.50). A
study published by McCormack et al (2005) did not find any
association between birth weight and the occurrence of melanoma
(hazard ratio¼1.03, 95% CI: 0.85–1.26). Ahlgren et al (2007)
observed a positive linear trend for birth weight and incidence of
melanoma (847 melanoma cases) with RR of 1.04 (95% CI: 1.00–
1.31). Our data confirm the results of the last study although with
nonsignificance. The study of Andersson and co-workers included
only six cases of melanoma, analysed together with other cancer
types under the term ‘nonhormonal cancers’, and the results are,
therefore, difficult to evaluate. McCormak’s study included 77
melanoma cases and the question of power is pertinent.
The observed tendency to reduced melanoma risk among twins
agrees with the tendency to lower risk among those with birth
weight below 2500g, as the mean birth weight for twins was 2640g.
Maternal preeclampsia/eclampsia, hypertension during pregnancy
and chronic kidney disease may influence the nutrition conditions
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yin the womb and often lead to undernutrition of the foetus. These
conditions were more frequent among controls than in the case
group. These observations might support our hypothesis that LBW
can reduce the risk of melanoma later in life.
In the present study, women have close to 2.5-fold risk of
developing melanoma compared to men. This is possibly due to
the different sun exposure habits between genders, but other
factors might also be involved. Individuals born in the south of
Norway had a 30% higher risk of melanoma compared to
individuals born in the north. This result is due to the latitude
gradients in UV exposure in Norway, which previously has been
shown to be reflected in the melanoma risk (Magnus, 1973;
Robsahm and Tretli, 2001; Cancer in Norway, 2006). No effect was
Table 1 Distribution of major variables in cases of malignant melanoma of the skin and controls without malignant disease
Variables Cases (N¼709) Controls (N¼108209) OR (95% CI) P-value*
Birth weight (grams)
Mean (s.d.) 3510.4 (540.9) 3507.8 (550.2) 0.900
Females: mean (s.d.) 3475.9 (533.4) 3441.3 (531.7) 0.154
Males: mean (s.d.) 3583.6 (550.7) 3567.8 (559.8) 0.671
Birth weight (grams)
o2500 (%) 23 (3.2) 4043 (3.7) 0.86 (0.57–1.31) 0.491
X2500 (%) 686 (96.8) 104166 (96.3) 1.00
Gender
Females (%) 482 (68.0) 51326 (47.4) 2.35 (2.01–2.76) o0.0001
Males (%) 227 (32.0) 56883 (52.6) 1.00
Place of birth
South Norway (%) 546 (77.0) 78007 (72.1) 1.30 (1.09–1.55) 0.004
North Norway (%) 163 (23.0) 30202 (27.9) 1.00
Mother’s age (years)
Mean (s.d.) 26.0 (5.1) 26.0 (5.2) 0.831
o29 (%) 524 (73.9) 76970 (71.1) 0.87 (0.74–1.03) 0.104
X29 (%) 185 (26.1) 31239 (28.9) 1.00
Father’s age (years)
a
Mean (s.d.) 29.7 (6.2) 29.7 (6.1) 0.844
o33 (%) 492 (72.7) 72978 (73.0) 1.02 (0.86–1.21) 0.827
X33 (%) 185 (27.3) 26926 (27.0) 1.00
Maternal pregnancy factors
Preeclampsia/eclampsia (%) 18 (2.5) 3799 (3.5) 0.72 (0.43–1.17) 1.161
Hypertension during pregnancy (%) 8 (1.1) 1487 (1.4) 0.82 (0.38–1.70) 0.575
Chronic kidney disease (%) 2 (0.3) 962 (0.9) 0.32 (0.05–1.28) 0.085
Anaemia (%) 4 (0.6) 586 (0.5) 1.04 (0.33–2.89) 0.796
Twin status
Twins+ (%) 10 (1.4) 2009 (1.9) 0.76 (0.40–1.41) 0.380
Singletons (%) 699 (98.6) 106200 (98.1) 1.00
CI¼confidence interval; OR¼odds ratio (crude); s.d.¼standard deviation; twins+¼twins, triplets, quadruplets and quintuplets. *All P-values are two sided.
aMissing data
n¼8337 individuals.
Table 2 Association between different levels of birth weight and








(N¼108209) OR 95% CI
o2500 23 4043 1.00
2500–3189 160 22909 1.23 (0.79–1.90)
3190–3519 176 26664 1.16 (0.75–1.79)
3520–3859 167 27506 1.07 (0.69–1.65)
X3860 183 27087 1.19 (0.77–1.84)
P for trend¼0.871
CI¼confidence interval; OR¼odds ratio.
Table 3 Birth weight and risk for malignant melanoma: adjustment for
multiconfounding effect of gender, place of birth and parental age at the
time of birth, using multivariate logistic model
Variable OR 95% CI P-value*
Birth weight (grams)
o2500 0.81 0.52–1.26 0.352
X2500 1.0
Gender
Female 2.38 2.02–2.80 o0.001
Male 1.0
Place of birth
South Norway 1.27 1.06–1.53 0.010
North Norway 1.0
Mother’s age
Continuous 0.99 0.96–1.01 0.236
Father’s age
Continuous 1.01 0.99–1.03 0.382
CI¼confidence interval; OR¼odds ratio. *All P-values are two sided.
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yfound for parental age on risk of melanoma, which agrees with the
results published by Janerich et al (1989).
Results from the present study indicate that LBW (o2500g)
might be associated with lower risk of melanoma later in life. Birth
weight is probably not a risk factor of melanoma, but it might be a
marker of other relevant factors. Investigation of other exposures
correlated with birth weight should therefore be investigated in the
future.
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